Drug Trial Radar · NCT04534439
Safety, Tolerability and Renal Effects of APX-115 in Subjects With Type 2 Diabetes and Nephropathy
Last checked: Nov 20, 2026Latest source record: Aug 25, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
140
Actual
Start
Aug 24, 2020
Primary completion
Jul 26, 2021
Study completion Aug 23, 2021
Sponsor
- Lead sponsor
- Aptabio Therapeutics, Inc.Industry
- Sponsor type
- Industry
- First posted
- Sep 1, 2020
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a proof of concept (PoC) trial to evaluate the safety, tolerability and renal effect of APX-115 in subjects with Type 2 diabetes and nephropathy.
Conditions
- Diabetic Nephropathies
- Diabetes Mellitus, Type 2
- Nephropathy, Diabetic
Interventions
APX-115Drug
oral administration of APX-115 400mg capsule once daily for 12 weeks
PlaceboDrug
oral administration of APX-115-matching placebo 400mg capsule once daily for 12 weeks
Primary outcomes
What the sponsor says the trial is designed to measure.
- Mean change in urine albumin to creatinine ratio (UACR) in APX-115 group compared to placebo groupTime frame: week 12
Locations
16 sites in 4 countries. Site status is shown where the registry gives one.
Pleven
Pleven, Bulgaria
Sveta Karidad
Plovdiv, Bulgaria
Diagnostic-consultative centre I
Sliven, Bulgaria
Hadzhi Dimitar
Sofia, Bulgaria
HERA
Sofia, Bulgaria
Medical center - Sveti Dimitar
Sofia, Bulgaria
Sirtuin
Sofia, Bulgaria
Sveta
Sofia, Bulgaria
Hristo Botev
Vratsa, Bulgaria
Sveti Panteleymon Yambol
Yambol, Bulgaria
Nefromed s.r.o
Prague, Czechia
Drug Research Center
Balatonfüred, Hungary
UNO MEDICAL Trials Kft.
Budapest, Hungary
Mint House Private Medical Center
Székesfehérvár, Hungary
Bezanijska Kosa
Belgrade, Serbia
Clinical Centre of Serbia, clinic for endocrinology, diabetes and metabolism diseases, department for obesity, metabolic and reproductive disorders
Belgrade, Serbia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.